Although this difference did not reach statistical significance, it is plausible that it contributed to the improved outcomes, considering that both reduced eGFR and its decline over time are associated with increased cardiovascular risk and mortality 6 , 7 .
← all excerpts
A gap in the prognostic score for atherosclerotic renovascular disease: the role of statins.
1
—
—